Lamellar Biomedical

company

About

Lamellar Biomedical develops novel healthcare products based on the mimicry or modification of the lamellar body secretory system.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£2.33M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jun 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£11.38M
Lamellar Biomedical has raised a total of £11.38M in funding over 2 rounds. Their latest funding was raised on May 8, 2017 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 8, 2017 Series C £5.75M 1 Invesco Detail
Jul 24, 2015 Series Unknown £2.33M 2 Detail
Jan 7, 2013 Series A £3.30M 2 Invesco Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Lamellar Biomedical is funded by 2 investors. Invesco and Barwell Plc are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco Yes Series C
Barwell Plc Series Unknown